Mirum Pharmaceuticals (MIRM) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Mirum Pharmaceuticals (MIRM) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Mirum Pharmaceuticals

· MIRM

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

5.684 B

-2.35%

General

Market Cap: $5.68B
Enterprise Value: $5.64B
Shares Outstanding: 60,980,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 81.70%
Operating Margin: -17.42%
Net Profit Margin: -139.18%
FCF Margin: -74.13%
ROA: -82.32%
ROE: -410.20%
ROIC: -13.09%
Current Ratio: 2.86
Debt-to-Equity: -72.97
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.01
P/S: 8.43
P/FCF: —
P/B: —
EV/EBITDA: -7.26

Growth

Rev 1Y: 54.74%
Rev 1Y Fwd Est: 33.88%
Rev 3Y (CAGR): 89.13%
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: $618.07M
Gross Margin: 81.70%
Operating Expenses: $612.78M
Operating Income: -$107.66M
Net Profit: -$860.21M

Balance Sheet

Cash and Equivalents: $330.73M
Working Capital: $413.52M
Total Assets: $1.04B
Net Debt: $429.82M
Total Liabilities: $1.06B
Total Equity: -$10.42M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$456.03M
Cash Flow from Investing: -$184.35M
Cash Flow from Financing: $776.69M
Free Cash Flow: -$458.17M
Capital Expenditures: $2.14M